Orathecin rubitecan regulatory update

The EMEA granted SUPG's European affiliate, EuroGen Pharmaceuticals Ltd., Orphan Medicinal Product designation for Orathecin to treat pancreatic cancer. The compound is being reviewed by FDA in the U....